| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.1B | $10.3B | $10.1B | $9.8B | $2.6B | $2.9B | $2.8B | $2.9B |
| Cost of Revenue | $3.2B | $2.9B | $2.8B | $2.7B | $2.6B | $2.5B | $2.5B | $2.4B |
| Gross Profit | $7.9B | $7.4B | $7.3B | $7.1B | $1.9B | $2.1B | $2.2B | $2.3B |
| R&D Expense | $1.6B | $1.5B | $1.5B | $1.3B | $1.3B | $1.1B | $1.2B | $1.3B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.3B | $2.3B | $1.9B | $2.4B | $2.9B | $2.7B | $2.3B | $2.2B |
| Net Income | $2.0B | $2.0B | $2.8B | $-1.3B | $2.0B | $0.8B | $0.6B | $0.8B |
| EPS (Basic) | $4.43 | $3.99 | $5.22 | $-2.27 | $3.25 | $1.23 | $0.69 | $0.81 |
| EPS (Diluted) | $4.34 | $3.94 | $5.19 | $-2.27 | $3.25 | $1.21 | $0.69 | $0.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.6B | $19.4B | $21.6B | $20.9B | $26.6B | $19.3B | $18.2B | $22.8B |
| Current Assets | $5.1B | $7.6B | $11.0B | $9.3B | $9.1B | $7.2B | $4.7B | $7.1B |
| Cash & Equivalents | $1.9B | $2.4B | $2.0B | $2.2B | $1.4B | $1.4B | $1.0B | $2.2B |
| Total Liabilities | $13.0B | $14.2B | $15.2B | $15.7B | $16.8B | $15.7B | $15.3B | $16.5B |
| Current Liabilities | $4.6B | $6.1B | $4.5B | $4.3B | $4.6B | $4.0B | $4.1B | $4.5B |
| Stockholders' Equity | $4.6B | $5.2B | $6.4B | $5.2B | $9.8B | $3.6B | $2.9B | $6.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $2.4B | $2.4B | $2.3B | $2.7B | $2.4B | $3.1B | $2.7B |
| Investing Cash Flow | $1.4B | $2.2B | $0.2B | $2.5B | $3.7B | $3.8B | $2.8B | $2.9B |
| Capital Expenditures | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.5B | $0.6B | $0.7B |
| Financing Cash Flow | $-3.7B | $-3.8B | $-2.5B | $-3.8B | $-6.5B | $-5.7B | $-7.1B | $-5.4B |